Last updated: September 1, 2023
Sponsor: Werium Assistive Solutions
Overall Status: Active - Enrolling
Phase
N/A
Condition
Osteoporosis
Treatment
Phase I - Early gait rehabilitation
Preliminary Phase
Phase II - Maintenance gait function ( with VR)
Clinical Study ID
NCT06025981
SWalker-II-VR
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Participants of both sexes over 65 years of age,
- Patients with a height of less than 180 cm,
- Patients weighing less than 90 kg,
- Patients who have suffered a hip fracture* and wish to participate in the study.
- In addition, they must sign and understand the informed consent form.
Exclusion
Exclusion Criteria:
- Cognitive status insufficient to understand and execute instructions given by thephysiotherapist.
- Patients needing rehabilitation after hip fracture may vary from a few days to afew weeks after the period of occurrence of the hip fracture, depending on thecomplications that could arise and the type of surgery used, with a pre-set limitof one month.
Study Design
Total Participants: 100
Treatment Group(s): 3
Primary Treatment: Phase I - Early gait rehabilitation
Phase:
Study Start date:
January 10, 2023
Estimated Completion Date:
December 30, 2023
Study Description
Connect with a study center
Werium Assistive Solutions
Arganda Del Rey, Madrid 28500
SpainSite Not Available
Albertia Servicios Sociosanitarios
Madrid, 28222
SpainSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.